HBV DNA Test Among Blood Donations May Require Two Amplification Targets

This study highlights the potential risk of HBV false-negative detection by commercial NAT reagents. The dual-target assay may be helpful for HBV screening and reduce the risk of false-negative detection.
Source: Indian Journal of Hematology and Blood Transfusion - Category: Hematology Source Type: research